AMRC insider files Rule 144 to sell 5,000 shares on NYSE

Rhea-AI Filing Summary

Ameresco, Inc. insider filing shows a proposed sale of 5,000 common shares acquired on 10/09/2025 through an exercise of stock options, with an aggregate market value of $192,950. The broker is listed as Morgan Stanley Smith Barney LLC and the sale is planned for 10/09/2025 on the NYSE. The filing also discloses multiple recent 10b5-1 sales by Mark Chiplock during September–October 2025, including trades on 10/01/2025 through 10/08/2025 totaling several transactions and proceeds reported per trade.

The filer certifies no undisclosed material adverse information and indicates cash payment on acquisition. This is a routine insider notice of proposed sale under Rule 144 and records prior 10b5-1 activity.

Positive

• Transaction is documented under Rule 144, indicating regulatory compliance
• Acquisition and sale appear contemporaneous (exercise on 10/09/2025 with planned sale same day), showing clear intent to monetize vested options
• Use of a broker (Morgan Stanley Smith Barney LLC) and 10b5-1 plan activity provide orderly trading mechanisms

Negative

• Multiple recent insider sales by the same person in Sept–Oct 2025 may raise investor attention
• Concentrated selling over a short period could exert modest downward pressure on the stock around 10/09/2025

Insights

Corporate Insider Transactions Analyst

TL;DR: An executive exercised options and intends to sell 5,000 shares for $192,950, with recent active 10b5-1 selling.

The transaction arises from an exercise of stock options on 10/09/2025 and the intended sale is planned the same day through Morgan Stanley Smith Barney LLC on the NYSE. The filing lists multiple prior 10b5-1 sales by Mark Chiplock between 09/15/2025 and 10/08/2025, showing ongoing liquidity events.

Dependence and risk center on market execution and potential investor perception: clustered insider sales over a short period can attract attention even if preplanned under 10b5-1. Watch for share price movement around 10/09/2025 and any follow-up filings updating actual sale proceeds.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5000	192950.00	34703659	10/09/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/09/2025	Exercise of Stock Options	Issuer			5000	10/09/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for MARK CHIPLOCK 111 Speen Street, Suite 410 Framingham MA 01701	Common	10/08/2025	3800	151051.90
10b5-1 Sales for MARK CHIPLOCK 111 Speen Street, Suite 410 Framingham MA 01701	Common	10/07/2025	5900	233134.37
10b5-1 Sales for MARK CHIPLOCK 111 Speen Street, Suite 410 Framingham MA 01701	Common	10/06/2025	5900	229628.00
10b5-1 Sales for MARK CHIPLOCK 111 Speen Street, Suite 410 Framingham MA 01701	Common	10/01/2025	5602	212595.90
MARK CHIPLOCK 111 Speen Street, Suite 410 Framingham MA 01701	Common	09/15/2025	269	7532.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did the Ameresco (AMRC) Form 144 report?

The Form 144 reports a proposed sale of 5,000 common shares acquired via exercise of stock options on 10/09/2025, with an aggregate market value of $192,950 and a planned sale date of 10/09/2025 on the NYSE.

Who is the broker handling the proposed sale in the AMRC filing?

The broker listed is Morgan Stanley Smith Barney LLC, located at 1 New York Plaza, New York, NY.

Did the filing disclose prior insider sales for AMRC?

Yes. The filing lists multiple 10b5-1 sales by Mark Chiplock between 09/15/2025 and 10/08/2025, with individual trade proceeds reported for each sale.

How much cash did the proposed 5,000-share sale represent?

The filing states an aggregate market value of $192,950 for the 5,000 shares proposed to be sold.

Was the acquisition paid in cash?

Yes. The acquisition table indicates the date of payment as 10/09/2025 and the nature of payment as Cash.